Die StiftungNeurowissenschaftenEuropäische IntegrationErziehung zur Demokratie
ghst
Förderbereiche>Neurowissenschaften>Publikationen - Neurowissenschaften
Aus den geförderten Forschungsprojekten der Hertie-Stiftung entstehen zahlreiche hochkarätige Originalarbeiten, die besondere Fortschritte in der Medizin bedeuten können. Bewertet werden Veröffentlichungen international nach Impact-Faktoren (IF), die für wissenschaftliche Zeitschriften vergeben werden nach deren Zitierhäufigkeit in der Literatur und die ein Maß für die Relevanz der veröffentlichten Forschungsergebnisse darstellen. Wir führen nach dem Vorbild des schwedischen Karolinska Instituts besonders hoch bewertete Originalarbeiten, die einen IF > 15 aufweisen, gesondert auf (bitte wählen Sie hierzu das entsprechende Themenfeld aus).  
Themenfeld wählen:

Seite: 1  2  3  4  5 ...
Stüttgen M.C., Schwarz C., Abteilung Kognitive Neurologie, Hertie-Institut für Klinische Hirnforschung, Universität Tübingen
Psychophysical and neurometric detection performance under stimulus uncertainty. Nature Neuroscience 11:1091-9.
2008  Veröffentlichungen IF > 15

Zusammenfassung:
Signal detection theoretical analyses of spike counts have revealed that some cortical neurons can exceed psychophysical sensitivity in cases where a sensory signal is specified exactly. It is not known whether this finding holds in the more natural situation where signal occurrence is temporally uncertain. We investigated the ability of rat barrel cortex neurons to detect faint and transient whisker deflections occurring at unspecified times. The progression from fully specified stimuli to temporal uncertainty degraded neuronal sensitivity such that it seems highly unlikely that single neurons can provide the basis for decoding uncertain perceptual events. However, modeling the sensitivity of neuronal pools on basis of spike timing precision across several neurons in an optimal encoding window of 25 ms showed that the subject's perceptual sensitivity could be based on the occurrence of coincident spikes from four to five neurons.

Prozorovski T., Schulze-Topphoff U., Glumm R., Baumgart J., Schröter F., Ninnemann O., Siegert E., Bendix I., Brüstle O., Nitsch R., Zipp F., Aktas O., Cecilie Vogt Klinik für Neurologie im Helios Klinikum Berlin-Buch, Charité-Universitätsmedizin Berlin und Max Delbrück Zentrum für Molekularmedizin sowie Mitwirkung des Institutes für Rekonstruktive Neurobiologie, Rheinische Friedrich-Wilhelms-Universität Bonn und andere
Sirt1 contributes critically to the redox-dependent fate of neural progenitors. Nature Cell Biology 10(4):373-4.
2008  Veröffentlichungen IF > 15

Zusammenfassung:
Repair processes that are activated in response to neuronal injury, be it inflammatory, ischaemic, metabolic, traumatic or other cause, are characterized by a failure to replenish neurons and by astrogliosis. The underlying molecular pathways, however, are poorly understood. Here, we show that subtle alterations of the redox state, found in different brain pathologies, regulate the fate of mouse neural progenitor cells (NPCs) through the histone deacetylase (HDAC) Sirt1. Mild oxidation or direct activation of Sirt1 suppressed proliferation of NPCs and directed their differentiation towards the astroglial lineage at the expense of the neuronal lineage, whereas reducing conditions had the opposite effect. Under oxidative conditions in vitro and in vivo, Sirt1 was upregulated in NPCs, bound to the transcription factor Hes1 and subsequently inhibited pro-neuronal Mash1. In utero shRNA-mediated knockdown of Sirt1 in NPCs prevented oxidation-mediated suppression of neurogenesis and caused upregulation of Mash1 in vivo. Our results provide evidence for an as yet unknown metabolic master switch that determines the fate of neural progenitors.

Kaeser S.A., Herzig M.C., Coomaraswamy J., Kilger E., Selenica M.L., Winkler D.T., Staufenbiel M., Levy E., Grubb A., Jucker M., Abteilung Zellbiologie Neurologischer Erkrankungen, Hertie-Institut für Klinische Hirnforschung, Universität Tübingen
Cystatin C modulates cerebral beta-amyloidosis. Nature Genetics 39(12):1437-9
2007  Veröffentlichungen IF > 15

Zusammenfassung:
The CST3 Thr25 allele of CST3, which encodes cystatin C, leads to reduced cystatin C secretion and conveys susceptibility to Alzheimer's disease. Here we show that overexpression of human cystatin C in brains of APP-transgenic mice reduces cerebral amyloid-beta deposition and that cystatin C binds amyloid-beta and inhibits its fibril formation. Our results suggest that cystatin C concentrations modulate cerebral amyloidosis risk and provide an opportunity for genetic risk assessment and therapeutic interventions.

Wahlström J., Dengjel J., Persson B., Duyar H., Rammensee H.G., Stevanović S., Eklund A., Weissert R., Grunewald J., Labor für Lungenforschung des Bereiches für Medizin, Karolinska Institut, Stockholm, Abteilung Allgemeine Neurologie unter Beteiligung von Mitarbeitern des Hertie-Institutes für Klinische Hirnforschung, Universität Tübingen und anderen
Identification of HLA-DR-bound peptides presented by human bronchoalveolar lavage cells in sarcoidosis. Journal of Clinical Investigation 117(11):3164-6  
2007  Veröffentlichungen IF > 15

Zusammenfassung:
Sarcoidosis is an inflammatory disease of unknown etiology, most commonly affecting the lungs. Activated CD4+ T cells accumulate in the lungs of individuals with sarcoidosis and are considered to be of central importance for inflammation. We have previously shown that Scandinavian sarcoidosis patients expressing the HLA-DR allele DRB1*0301 are characterized by large accumulations in the lungs of CD4+ T cells expressing the TCR AV2S3 gene segment. This association afforded us a unique opportunity to identify a sarcoidosis-specific antigen recognized by AV2S3+ T cells. To identify candidates for the postulated sarcoidosis-specific antigen, lung cells from 16 HLA-DRB1*0301pos patients were obtained by bronchoalveolar lavage. HLA-DR molecules were affinity purified and bound peptides acid eluted. Subsequently, peptides were separated by reversed-phase HPLC and analyzed by liquid chromatography-mass spectrometry. We identified 78 amino acid sequences from self proteins presented in the lungs of sarcoidosis patients, some of which were well-known autoantigens such as vimentin and ATP synthase. For the first time, to our knowledge, we have identified HLA-bound peptides presented in vivo during an inflammatory condition. This approach can be extended to characterize HLA-bound peptides in various autoimmune settings.

Meyer-Luehmann M., Coomaraswamy J., Bolmont T., Kaeser S., Schaefer C., Kilger E., Neuenschwander A., Abramowski D., Frey P., Jaton A.L., Vigouret J.M., Paganetti P., Walsh D.M., Mathews P.M., Ghiso J., Staufenbiel M., Walker L.C., Jucker M., Abteilung Zellbiologie Neurologischer Erkrankungen, Hertie-Institut für Klinische Hirnforschung, Universität Tübingen
Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science, 2006 Sep 22; 313 (5794):1781-1784
2006  Veröffentlichungen IF > 15
Zusammenfassung:
Department of Cellular Neurology, Hertie-Institute for Clinical Brain Research, University of Tubingen, D-72076 Tubingen, Germany.Protein aggregation is an established pathogenic mechanism in Alzheimer's disease, but little is known about the initiation of this process in vivo. Intracerebral injection of dilute, amyloid-beta (Abeta)-containing brain extracts from humans with Alzheimer's disease or beta-amyloid precursor protein (APP) transgenic mice induced cerebral beta-amyloidosis and associated pathology in APP transgenic mice in a time- and concentration-dependent manner. The seeding activity of brain extracts was reduced or abolished by Abeta immunodepletion, protein denaturation, or by Abeta immunization of the host. The phenotype of the exogenously induced amyloidosis depended on both the host and the source of the agent, suggesting the existence of polymorphic Abeta strains with varying biological activities reminiscent of prion strains.
Ramirez A., Heimbach A., Gründemann J., Stiller B., Hampshire D., Cid L.P., Goebel I., Mubaidin A.F., Wriekat A.L. , Roeper J., Hillmer A.M., Karsak M., Liss B., Woods C.G., Behrens M.I., Kubisch C., Institute für Humangenetik und Genetik sowie Zentrum für Molekulare Medizin der Universität Köln, Molekulare Neurobiologie am Institut für Physiologie und Pathophysiologie der Philipps-Universität Marburg und andere
Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nature Genetics, 2006, Vol. 38, Nr. 10:1184-1191
2006  Veröffentlichungen IF > 15
Zusammenfassung:
Neurodegenerative disorders such as Parkinson and Alzheimer disease cause motor and cognitive dysfunction and belong to a heterogeneous group of common and disabling disorders. Although the complex molecular pathophysiology of neurodegeneration is largely unknown, major advances have been achieved by elucidating the genetic defects underlying mendelian forms of these diseases. This has led to the discovery of common pathophysiological pathways such as enhanced oxidative stress, protein misfolding and aggregation and dysfunction of the ubiquitin-proteasome system. Here, we describe loss-of-function mutations in a previously uncharacterized, predominantly neuronal P-type ATPase gene, ATP13A2, underlying an autosomal recessive form of early-onset parkinsonism with pyramidal degeneration and dementia (PARK9, Kufor-Rakeb syndrome). Whereas the wild-type protein was located in the lysosome of transiently transfected cells, the unstable truncated mutants were retained in the endoplasmic reticulum and degraded by the proteasome. Our findings link a class of proteins with unknown function and substrate specificity to the protein networks implicated in neurodegeneration and parkinsonism.
Alle H., Geiger J., Hertie-Nachwuchsgruppe „Synaptische Regulation und Funktion”, Max-Planck-Institut für Hirnforschung, Frankfurt
Combined Analog and Action Potential Coding in Hippocampal Mossy Fibers. Science, Vol. 311:1290-93
2006  Veröffentlichungen IF > 15
Zusammenfassung:
In the mammalian cortex, it is generally assumed that the output information of neurons is encoded in the number and the timing of action potentials. Here, we show, by using direct patchclamp recordings from presynaptic hippocampal mossy fiber boutons, that axons transmit analog signals in addition to action potentials. Excitatory presynaptic potentials result from subthreshold dendritic synaptic inputs, which propagate several hundreds of micrometers along the axon and modulate action potential-evoked transmitter release at the mossy fiber-CA3 synapse. This combined analog and action potential coding represents an additional mechanism for information transmission in a major hippocampal pathway.   
Schilling S, R Linker, F König, M Kozlolek, M Bähr, G Müller, W Paulus, J Gärtner, W Brück, A Chan, R Gold
Plasmaaustausch bei steroidresistenten Multiple Sklerose-Schüben
2006  MS-Forschung
Der Nervenarzt 77: 430-438 (2006) 
E-Mail: a.chan@med.uni-goettingen.de
Gold R, HP Hartung, R Hohlfeld
Monoklonale Antikörper verbessern Behandlung der schubförmigen Multiplen Sklerose
2006  MS-Forschung
Dtsch Med Wochenschr 131: 31-34 (226)
E-Mail: r.gold@med.uni-goettingen.de
Krumholz M, Theil D, Derfuss T, A Rosenwald, F Schrader, CM Monoranu, SL Kalled, DM Hess, B Serafini, F Aloisi, H Wekerle, R Hohlfeld, E Meinl
BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma
2005  MS-Forschung
The Journal of Experimental Medicine 201: 195-200
E-Mail: meinl@neuro.mpg.de
Stefan K, M Wycislo, R Gentner, A Schramm, M Naumann, KH Reiners, J Classen
Temporary Occlusion of Associative Motor Cortical Plasticity by Prior Dynamic Motor Training
2005  
Cerebral Cortex (2005)
E-Mail:
Nogai A, V Siffrin, K Bonhagen, CF Pfueller, T Hohnstein, R Volkmer-Engert, W Brück, C Stadelmann, T Kamradt
Lipopolysaccharide Injection Induces Relapses of Experimental Autoimmune Encephalomyelitis in Nontransgenic Mice via Bystander Activation of Autoreactive CD4+ Cells
2005  MS-Forschung
The Journal of Immunology 175: 959-966 (2005)
e-Mail: Immunologie@mti.uni-jena.de
Magnus T, B Schreiner, T Korn, C Jack, H Guo, J Antel, I Ifergan, L Chen, F Bischof, A Bar-Or, H Wiendl
Microglial Expression of the B7 Family Member B7 Homolog 1 Confers Strong Immune Inhibition: Implications for Immune Responses and Autoimmunity in the CNS
2005  MS-Forschung
The Journal of Neuroscience 25: 2537-2546
E-Mail: heinz.wiendl@klinik.uni-wuerzburg.de
Fritzsching B, N Oberle, N Eberhardt, S Quick, J Haas, B Wildemann, PH Krammer, E Suri-Payer
Cutting Edge: In Contrast to Effector T Cells, CD4+ CD25+ FoxP3+ Regulatory T Cells Are Highly Susceptible to CD95 Ligand- but Not to TCR-Mediated Cell Death 
2005  MS-Forschung
The Journal of Immunology 175: 32-36 (2005)
E-Mail: Benedikt.Fritzsching@dkfz.de
Liss B., Haeckel O., Wildmann J., Miki T., Seino S., Roeper J., Molekulare Neurobiologie, Institut für Physiologie und Pathophysiologie der Philipps-Universität Marburg
K-ATP channels promote the differential degeneration of dopaminergic midbrain neurons. Nature neuroscience, Vol. 8 (12):1742-51
2005  Veröffentlichungen IF > 15
Zusammenfassung:
The selective degeneration of dopaminergic (DA) midbrain neurons in the substantia nigra (SN) is a hallmark of Parkinson disease. DA neurons in the neighbouring ventral tegmental area (VTA) are significantly less affected. The mechanisms for this differential vulnerability of DA neurons are unknown. We identified selective activation of ATP-sensitive potassium (K-ATP) channels as a potential mechanism. We show that in response to parkinsonism-inducing toxins, electrophysiological activity of SN DA neurons, but not VTA DA neurons, is lost owing to activation of K-ATP channels. This selective K-ATP channel activation is controlled by differences in mitochondrial uncoupling between SN and VTA DA neurons. Genetic inactivation of the K-ATP channel pore-forming subunit Kir6.2 resulted in a selective rescue of SN but not VTA DA neurons in two mechanistically distinct mouse models of dopaminergic degeneration, the neurotoxicological 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model and the mutant weaver mouse. Thus, K-ATP channel activation has an unexpected role in promoting death of DA neurons in chronic disease. 
Takahashi K., Rochford C., Neumann H. (2005), Forschergruppe Neuroimmunologie des European Neuroscience Institute (ENI) an der Universität Göttingen
Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. Journal of Experimental Medicine, Vol. 201(4):647-657
2005  Veröffentlichungen IF > 15
Zusammenfassung:
Elimination of apoptotic neurons without inflammation is crucial for brain tissue homeostasis, but the molecular mechanism has not been firmly established. Triggering receptor expressed on myeloid cells-2 (TREM2) is a recently identified innate immune receptor. Here, we show expression of TREM2 in microglia. TREM2 stimulation induced DAP12 phosphorylation, extracellular signal-regulated kinase phosphorylation, and cytoskeleton reorganization and increased phagocytosis. Knockdown of TREM2 in microglia inhibited phagocytosis of apoptotic neurons and increased gene transcription of tumor necrosis factor alpha and nitric oxide synthase-2, whereas overexpression of TREM2 increased phagocytosis and decreased microglial proinflammatory responses. Thus, TREM2 deficiency results in impaired clearance of apoptotic neurons and inflammation that might be responsible for the brain degeneration observed in patients with polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy/Nasu-Hakola disease. 
Saher G., Brügger B., Lappe-Siefke C., Möbius W., Tozawa R., Wehr M., Wieland F., Ishibashi S., Nave K.-A., Abteilung für Neurogenetik, Max-Planck-Institut für Experimentelle Medizin, Göttingen
High cholesterol level is essential for myelin membrane growth.Nature Neuroscience, Vol. 8 (4):468-475
2005  Veröffentlichungen IF > 15
Zusammenfassung:
Cholesterol in the mammalian brain is a risk factor for certain neurodegenerative diseases, raising the question of its normal function. In the mature brain, the highest cholesterol content is found in myelin. We therefore created mice that lack the ability to synthesize cholesterol in myelin-forming oligodendrocytes. Mutant oligodendrocytes survived, but CNS myelination was severely perturbed, and mutant mice showed ataxia and tremor. CNS myelination continued at a reduced rate for many months, and during this period, the cholesterol-deficient oligodendrocytes actively enriched cholesterol and assembled myelin with >70% of the cholesterol content of wild-type myelin. This shows that cholesterol is an indispensable component of myelin membranes and that cholesterol availability in oligodendrocytes is a rate-limiting factor for brain maturation. 
Gold R, C Stadelmann, R Linker, R Diem, M Bähr, W Brück
Neue Erkenntnisse zur Pathogenese der multiplen SklerosePotential für die Erweiterung der therapeutischen Optionen
2005  MS-Forschung
Deutsches Ärzteblatt 17: 951-956 (2005)
E-Mail: r.gold@med.uni-goettingen.de
Cepok S, D Zhou, R Srivastava, S Nessier, S Stei, K Büssow, N Sommer, B Hemmer
Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis
2005  MS-Forschung
The Journal of Clinical Investigation 115: 1352-1360 (2005) 
E-mail: bernhard.hemmer@uni-duesselsorf.de
Magnus T, T Korn, S Jung
Chronically stimulated microglial cells do no longer alter their immune functions in response to the phagocytosis of apoptotic cells
2004  MS-Forschung
Journal of Neuroimmunology 155: 64-72 (2004)
E-Mail: netmag@uniklinik-saarland.de
Seite: 1  2  3  4  5 ...

Seite in Druckansicht darstellen